Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
6.70
0.00 (0.00%)
Oct 6, 2026, 11:52 AM EDT - Market open
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $532.18 million as of October 6, 2026. Its market cap has decreased by -38.56% in one year.
Market Cap
532.18M
Enterprise Value
901.73M
1-Year Change
-38.56%
Ranking
Category
Stock Price
$6.70
ChartMarket Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $532.18M, an increase of 0.96%. That is a compound annual growth rate of 0.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 532.18M | -54.91% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 574.44M |
| CorMedix | 560.42M |
| CytomX Therapeutics | 557.82M |
| MapLight Therapeutics | 545.75M |
| Valneva SE | 540.23M |
| Oculis Holding AG | 538.92M |
| Altimmune | 532.01M |
| Prime Medicine | 530.15M |